Core Viewpoint - The announcement details the upcoming listing and circulation of 6,390,100 restricted shares of Zhejiang Haizheng Biomaterials Co., Ltd., which will be available for trading starting August 18, 2025, following the expiration of the lock-up period for certain shareholders [1][2]. Summary by Sections Listing Details - The total number of shares to be listed is 6,390,100, representing 3.15% of the company's total share capital [2][9]. - The shares will be available for trading on August 18, 2025, due to the preceding non-trading day on August 16, 2025 [1][2]. Shareholder Information - The restricted shares are held by three entities: Taizhou Jiaojiang Chuanghe Enterprise Management Partnership (Limited Partnership), Taizhou Jiaojiang Chuangyou Enterprise Management Partnership (Limited Partnership), and Taizhou Chuangyi Enterprise Management Service Center (Limited Partnership) [2][9]. - The lock-up period for these shareholders was 36 months from the date of the company's initial public offering [2][3]. Changes in Share Capital - Since the formation of these restricted shares, there have been no changes in the company's share capital due to profit distribution or capital increase [2]. Commitments from Shareholders - The shareholders have committed not to transfer or manage their shares for 36 months post-IPO and must comply with relevant regulations during any future share reductions [3][4]. - Any income gained from violations of these commitments must be returned to the company [3][4]. Lock-up Period Extension - The lock-up period for certain shareholders was automatically extended by six months due to the company's stock price falling below the IPO price for 20 consecutive trading days [7][10]. - The new lock-up expiration date is February 15, 2026 [10]. Verification by Intermediaries - The sponsor, CITIC Securities Co., Ltd., confirmed that the listing of the restricted shares complies with relevant laws and regulations [8][9].

Core Viewpoint - The announcement from Haizheng Shengcai regarding the listing of restricted shares indicates a significant event for the company, as it marks the first public offering of restricted shares, which may impact the stock's liquidity and investor sentiment [1] Summary by Relevant Sections - **Stock Listing Details** - The total number of shares to be listed for circulation is 6,390,100 shares [1] - The listing date for these shares is set for August 18, 2025 [1] - **Subscription Method** - The method of stock subscription is through offline channels [1]

证券代码：688203 证券简称：海正生材 公告编号：2025-44 重要内容提示： 本次股票上市类型为首发限售股份；股票认购方式为网下，上市股数为 6,390,100股。 本次股票上市流通总数为6,390,100股。 浙江海正生物材料股份有限公司 本次股票上市流通日期为2025 年 8 月 18 日。因 2025 年 8 月 16 日为非交 易日，上市流通日顺延至 2025 年 8 月 18 日。 首次公开发行部分限售股上市流通公告 一、本次上市流通的限售股类型 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据中国证券监督管理委员会《关于同意浙江海正生物材料股份有限公司首 次公开发行股票注册的批复》（证监许可[2022]847 号），同意公司首次公开发行股 票的注册申请。并经上海证券交易所同意，公司首次向社会公众公开发行 A 股股 票 50,669,517 股，并于 2022 年 8 月 16 日在上海证券交易所科创板上市，发行完 成后总股本为 202,678,068 股，其中有限售条件流通股为 156,470,89 ...

中信建投证券股份有限公司 关于浙江海正生物材料股份有限公司 （一）本次限售股上市流通的有关股东台州市椒江创和企业管理合伙企业 （有限合伙）、台州市椒江创友企业管理合伙企业（有限合伙）、台州创熠企业 管理服务中心（有限合伙）承诺内容具体如下： （1）本企业自发行人股票上市之日起36个月内，不转让或者委托他人管理 本企业于发行人公开发行股票前已持有的发行人股份，也不由发行人回购本企业 于发行人公开发行股票前已持有的发行人股份。 首次公开发行部分限售股上市流通的核查意见 中信建投证券股份有限公司（以下简称"中信建投证券"或"保荐机构"）作为 浙江海正生物材料股份有限公司（以下简称"海正生材"或"公司"）首次公开发行 股票并在科创板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《上 海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管 规则适用指引第1号——规范运作》等有关法律法规规定，对海正生材首次公开 发行部分限售股上市流通事项进行了核查，具体情况如下： 一、本次上市流通的限售股类型 根据中国证券监督管理委员会《关于同意浙江海正生物材料股份有限公司首 次公开发行股票注册的批复》（证监许可[ ...

格隆汇8月8日丨海正生材(688203.SH)公布，公司本次股票上市流通总数为639.01万股。本次股票上市流 通日期为2025年8月18日。因2025年8月16日为非交易日，上市流通日顺延至2025年8月18日。 ...

Group 1: Desktop 3D Printing Market - The global desktop 3D printing market is projected to grow from $5.9 billion in 2024 to $20.9 billion by 2030, with a CAGR of 23% [14][11]. - In 2023, China's desktop 3D printing market size was $300 million, accounting for approximately 6% of the global market, with key applications in dental/healthcare (24%), jewelry (21%), and food (19%) [14][12]. - The desktop 3D printing technology is categorized into FDM and SLA, with FDM being more cost-effective but less precise compared to SLA [14][13]. Group 2: Competitive Landscape - Bambu Lab is a leading player in the desktop 3D printing market, achieving revenues of 2.7 billion yuan in 2023, with a projected revenue of 5.5 billion yuan in 2024 [28]. - Creality, established in 2014, has sold over 5.5 million 3D printers globally, maintaining a market share of approximately 39% in the entry-level segment [29]. - Voxelab, founded in 2015, has launched over 20 products and achieved annual revenues exceeding 1 billion yuan, focusing on cost-effective solutions [35]. Group 3: Laser Engraving Market - The global laser engraving market is expected to reach $4.4457 billion in 2024, with a CAGR of 8.7% from 2025 to 2030 [47]. - The desktop laser engraving machine market is growing rapidly, with a 23% increase in sales from 2022 to 2023, reaching 370,000 units sold [47][48]. - Major players in the laser engraving market include xTool, Ortur, and Atomstack, with xTool holding a significant market share [50][54]. Group 4: Key Companies and Financials - Bambu Lab's community forum has over 100,000 members, enhancing user engagement and product adoption [28]. - xTool's revenue exceeded 1 billion yuan in 2023, with projections of 2 to 3 billion yuan in 2024, aiming for over 5 billion yuan by 2025 [54]. - The laser control system supplier, Jin Chengzi, is expected to generate revenue of 212 million yuan in 2024, with a net profit margin of 13.9% [65].

Group 1 - The company announced a share repurchase plan with a total expected amount between 20 million to 30 million RMB [1] - The repurchase period is set from August 28, 2024, to August 27, 2025 [1] - The repurchased shares will be used for employee stock ownership plans or equity incentives [1] Group 2 - As of the latest update, the company has repurchased a total of 1,482,364 shares, representing 0.731% of the total share capital [1] - The total amount spent on repurchased shares is 14,288,602.36 RMB, with a price range of 7.76 RMB to 10.53 RMB per share [1][2] - The company will continue to make repurchase decisions based on market conditions and will fulfill its information disclosure obligations [2]

Core Viewpoint - The company, Haizheng Shengcai, announced that it has not repurchased any shares as of July 2025 [1] Summary by Relevant Categories - **Company Announcement** - Haizheng Shengcai released a statement on August 1, indicating that there have been no share repurchases up to July 2025 [1]

格隆汇8月1日丨海正生材(688203.SH)公布，2025年7月，公司未回购股份。截至2025年7月31日，公司 通过上海证券交易所交易系统以集中竞价交易方式已累计回购公司股份1,482,364股，占公司目前总股本 202,678,068股的比例为0.731%，回购成交的最高价为10.53元/股，最低价为7.76元/股，支付的资金总额 为人民币14,288,602.36元（不含印花税、交易佣金等交易费用）。 ...

格隆汇8月1日丨海正生材(688203.SH)公布，2025年7月，公司未回购股份。截至2025年7月31日，公司 通过上海证券交易所交易系统以集中竞价交易方式已累计回购公司股份1,482,364股，占公司目前总股本 202,678,068股的比例为0.731%，回购成交的最高价为10.53元/股，最低价为7.76元/股，支付的资金总额 为人民币14,288,602.36元（不含印花税、交易佣金等交易费用）。 ...